Athira Pharma (ATHA)
NASDAQ:ATHA
US Market
Holding ATHA?
Track your performance easily

Athira Pharma (ATHA) Financial Statements

528 Followers

Athira Pharma Financial Overview

Athira Pharma's market cap is currently ―. The company's EPS TTM is $-2.969; its P/E ratio is -0.20; Athira Pharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -26.86M$ -26.34M-$ -32.97M$ -29.60M
EBITDA$ -26.29M$ -26.30M-$ -33.07M$ -29.71M
Net Income Common Stockholders$ -26.86M$ -26.30M$ -27.55M$ -32.97M$ -29.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 91.77M$ 122.09M$ 147.42M$ 172.95M$ 186.09M
Total Assets$ 111.25M$ 133.46M$ 160.25M$ 184.70M$ 208.05M
Total Debt$ 1.41M$ 1.50M$ 1.58M$ 1.67M$ 1.75M
Net Debt$ -90.36M$ -120.59M$ -145.83M$ -171.28M$ -184.34M
Total Liabilities$ 27.92M$ 26.72M$ 30.06M$ 29.94M$ 23.07M
Stockholders Equity$ 83.33M$ 106.74M$ 130.19M$ 154.76M$ 184.98M
Cash Flow-
Free Cash Flow$ -22.36M$ -25.81M-$ -24.01M$ -24.32M
Operating Cash Flow$ -22.33M$ -25.80M$ -26.29M$ -23.98M$ -24.28M
Investing Cash Flow$ 26.56M$ 13.04M$ 6.39M$ 20.69M$ 32.49M
Financing Cash Flow$ 148.00K-$ 152.00K-$ 242.00K
Currency in USD

Athira Pharma Earnings and Revenue History

Athira Pharma Debt to Assets

Athira Pharma Cash Flow

Athira Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis